RLAY

NASD Relay Therapeutics, Inc.
Oct 3, 2026 · 10:36 AM ET EOD Market Closed

$18.96 ↑ +0.00 (+0.00%) Trading Up from the previous close of $18.96, $0.17 below the day’s high of $19.13

YTD change
+124.11%
vs 20-day SMA
+1.98%
vs 200-day SMA
+35.85%

Price ranges

Previous day
$18.60 $19.13
open $18.71 close $18.96
+$0.25 (+1.34%)
Today
$18.60 $19.13
$18.96
Past week
$17.05 $19.08
from $17.73 now $18.96
+$1.23 (+6.94%)
Past month
$17.05 $19.69
from $18.51 now $18.96
+$0.45 (+2.43%)
This year
$7.01 $21.27
from $8.46 now $18.96
+$10.50 (+124.11%)

Price & Performance

+6.51 (+52.29%) / 6M

$11.38$14.73$18.09$21.44Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 70.5% away from all-time highs of $64.37
  • RLAY is up 124% since the beginning of the year
  • RLAY is up 263% over the past 12 months
  • RLAY is up 2% over the past 1 month
  • 26% of all RLAY investors are betting against RLAY

RLAY reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +246.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.41
Earnings momentum -3.4% Quarterly EPS growth
Quarterly change -3.4%

Valuation

P/E ratio N/A
Enterprise value $2.9B
Beta 2.10

Balance sheet & scale

IncomeN/A
Revenue$10.3M
Cash$910.9M
Debt$30.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $4.2B

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $403.04 -1.04%
MRNA Moderna, Inc. $190.01 +0.57%
RVMD Revolution Medicines, Inc. $206.64 +0.36%
ROIV Roivant Sciences Ltd. $35.72 +0.62%
BNTX BioNTech SE Sponsored ADR $96.90 +0.05%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.